Thapar, Nikhil
Benninga, Marc A.
Crowell, Michael D.
Di Lorenzo, Carlo
Mack, Isabelle
Nurko, Samuel
Saps, Miguel
Shulman, Robert J.
Szajewska, Hania
van Tilburg, Miranda A. L.
Enck, Paul
Article History
Accepted: 15 September 2020
First Online: 5 November 2020
Competing interests
: N.T. has received grants, membership on advisory boards, speaker fees or travel support from Danone, Nutricia and Takeda. M.A.B. has received grants, membership on advisory boards, speaker fees or travel support from Abbott, Allergan, Coloplast, Danone, Friesland Campina, HIPP, Johnson & Johnson, Norgine, Shire, Sucampo and United Pharmaceuticals. C.D.L. has received grants, membership on advisory boards, speaker fees or travel support from Allergan, Mahana, Mallinckrodt, QOL, Sucampo and Takeda. M.S. has received grants, membership on advisory boards, speaker fees or travel support from Abbott, Allergan, Forest, QOL and Sucampo. H.S. has received grants, membership on advisory boards, speaker fees or travel support from Arla, Biocodex, Biogaia, Ch.Hansen, Danone, Merck, Nestlé and Nutricia. M.A.L.v.T. has received consultancy fees from Mahana. P.E. has received grants, membership on advisory boards, speaker fees or travel support from Alimentary Health, Aptinyx, Arena, Biocodex, CEMET, Danone, Genetic Analysis, Indigo, Merz, MDC, Sanofi, SymbioPharm and 4DPharma. All other authors declare no competing interests.
Free to read: This content has been made available to all.